Last updated on November 2017

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder


Brief description of study

A Randomized, Double-blind, Active-controlled Trial to Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Detailed Study Description

Assess the Efficacy and Safety of AXS-05 Administered Orally to Subjects with Treatment Resistant Major Depressive Disorder

Clinical Study Identifier: TX11110

Contact Investigators or Research Sites near you

Start Over

Jay Dobson

Northwest Clinical Research Center
Bellevue, WA USA